Fenofibrate and Appetite disorder - a phase IV clinical study of FDA data

Summary:

Appetite disorder is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are female, 50-59 old, also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Appetite disorder when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Appetite disorder?

Appetite disorder (abnormal eating habits) is found to be associated with 714 drugs and 706 conditions by eHealthMe. Check the latest studies of Appetite disorder.

On Jul, 07, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 22 people (0.06%) have Appetite disorder.

Could Fenofibrate cause Appetite disorder?

Among these 22 people:

What is the gender of people who have Appetite disorder when taking Fenofibrate? *

female: 57.89 %
male: 42.11 %

What is the age of people who have Appetite disorder when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

Metformin: 6 people, 27.27%
Vitamin D3: 5 people, 22.73%
Fish Oil: 5 people, 22.73%
Actos: 4 people, 18.18%
Percocet: 4 people, 18.18%
Flonase Allergy Relief: 3 people, 13.64%
Oxycontin: 3 people, 13.64%
Prilosec: 3 people, 13.64%
Qvar: 3 people, 13.64%
Magnesium: 3 people, 13.64%

What are other side effects people have besides Appetite disorder? *

Fatigue (feeling of tiredness): 9 people, 40.91%
Headache (pain in head): 7 people, 31.82%
Weight Decreased: 7 people, 31.82%
Nausea (feeling of having an urge to vomit): 7 people, 31.82%
Diarrhea: 7 people, 31.82%
Weight Increased: 6 people, 27.27%
Weakness: 5 people, 22.73%
High Blood Pressure: 5 people, 22.73%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 22.73%
Fall: 4 people, 18.18%

What are the existing conditions these people have? *

Type 2 Diabetes: 6 people, 27.27%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 18.18%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 13.64%
Pain: 3 people, 13.64%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 9.09%
Diabetes: 2 people, 9.09%
Muscle Aches (muscle pain): 2 people, 9.09%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 9.09%
Affective Disorder (mental disorder): 2 people, 9.09%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Appetite disorder?

- Check whether Appetite disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,456 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite disorder:

Appetite disorder (714 drugs)

Browse all the conditions that are associated with Appetite disorder:

Appetite disorder (706 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.